Indeed, the overexpression of AKR1B1 in transgenic mice has been shown to accelerate the onset of diabetic cataracts [69] and exacerbate diabetic cardiomyopathy [70]. This evidence concerns the gene AKR1B1 and diabetic cardiomyopathy.